Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Equity (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Return on Equity for 6 consecutive years, with 0.19% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 5.0% to 0.19% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.19% through Dec 2025, down 5.0% year-over-year, with the annual reading at 0.21% for FY2025, 5.0% down from the prior year.
  • Return on Equity hit 0.19% in Q4 2025 for Harmony Biosciences Holdings, down from 0.23% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.53% in Q3 2022 to a low of 0.08% in Q3 2021.
  • Historically, Return on Equity has averaged 0.26% across 5 years, with a median of 0.24% in 2025.
  • Biggest YoY gain for Return on Equity was 59bps in 2021; the steepest drop was -29bps in 2021.
  • Year by year, Return on Equity stood at 0.2% in 2021, then skyrocketed by 138bps to 0.49% in 2022, then tumbled by -50bps to 0.24% in 2023, then dropped by -5bps to 0.23% in 2024, then decreased by -20bps to 0.19% in 2025.
  • Business Quant data shows Return on Equity for HRMY at 0.19% in Q4 2025, 0.23% in Q3 2025, and 0.24% in Q2 2025.